This startup raised $250 million to help dogs live longer

Longevity Fund-backed Loyal is working toward FDA approval of a drug that could help dogs live longer, healthier lives. A canine health startup called Loyal has now raised more than $250 million to develop drugs that could help dogs—and perhaps one day humans—live longer, healthier lives.